Rivastigmine in the treatment of dementia in Alzheimer's disease in adults with Down syndrome

A study on the effectiveness of using rivastigmine to treat dementia in Alzheimer's disease patients with Down syndrome is presented. The small sample size of the study and non-significant results show that more research must be done before any conclusions can be drawn concerning the drug'...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of geriatric psychiatry 2005-05, Vol.20 (5), p.496-497
Hauptverfasser:	Prasher, V. P., Fung, N., Adams, C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer Disease - complications Alzheimer Disease - drug therapy Alzheimer's disease Biological and medical sciences Cholinesterase Inhibitors - therapeutic use Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Dementia Down Syndrome - complications Downs syndrome Drug therapy Effectiveness studies Female Fundamental and applied biological sciences. Psychology Geriatric psychiatry Geriatrics Humans Inhibitor drugs Male Medical sciences Middle Aged Neurology Nootropic Agents - therapeutic use Phenylcarbamates - therapeutic use Psychoanalysis Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Rivastigmine Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A study on the effectiveness of using rivastigmine to treat dementia in Alzheimer's disease patients with Down syndrome is presented. The small sample size of the study and non-significant results show that more research must be done before any conclusions can be drawn concerning the drug's effectiveness in this particular segment of Alzheimer's patients.
ISSN:	0885-6230 1099-1166
DOI:	10.1002/gps.1306